Diagnosis and Management of the Antiphospholipid Syndrome
BMJ 340:1125-1132, Cohen,D., et al, 2010
2024 Guide for the Primary Prevention of Stroke:A Guideline From the American Heart Association/American Stroke Association
Stroke 55:e344-e424, Bushnell,C.,et al, 2024
Susac Syndrome
Medicine 77:3-11, Papo,T.,et al, 1998
Coagulation Factor Expression and Composition of Arterial Thrombi in Cancer-Associated Stroke
Stroke 54:2981-2989, Yoo,J.,et al, 2023
Cerebral Microbleeds
Stroke 52:2347-2355, Graff-Radford, J.,et al, 2021
Caudal Epidural Steroid Injections in the Setting of Remaining on Antithrombotics: A Retrospective Study
Pain Physician 24:e821-e828, Simon,J.I.,et al, 2021
Antiplatelet and Anticoagulant Risk for Select Spine Interventions:A Retrospective Cohort
Pain Med 21:910-917, Ehsanian,R.,et al, 2020
Antiplatelet and Anticoagulant Agents for Secondary Prevention of Thromboembolic Events in People with Antiphospholipid Syndrome
Stroke 49:e41-e42, Bala, M.M.,et al, 2018
An unusual cause of stroke and hypoxia
BMJ 342:c7200, Bell, S.L. & Eveson, D.J., 2011
Early Lacunar Strokes Complicating Polyarteritis Nodosa
Neurol 54:883-889, Reichhart,M.D.,et al, 2000
Ticlopidine
Editorial, Lancet 337:459-4601991., , 1991
Antithrombotic Therapy in Cerebrovascular Disease
Ann Int Med 115:885-895, Rothrock,J.F.&Hart,R.G., 1991
Amaurosis Fugax Associated with Antiphospholipid Antibodies
Ann Neurol 25:228-232, Digre,K.B.,et al, 1989
The Canadian American Ticlopidine Study (CATS) in Thromboembolic Stroke
Lancet 1:1215-1220, Gent,M.,et al, 1989
Current Medical & Surgical Therapy for Cerebrovascular Disease
NEJM 317:1505-1516, Grotta,J.C., 1987
Therapy of Ischemic Cerebrovascular Disease
Ann Int Med 93:742-756, Byer,J.A.,et al, 1980